Your browser doesn't support javascript.
loading
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
Patoulias, Dimitrios; Popovic, Djordje S; Stoian, Anca Pantea; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi.
Affiliation
  • Patoulias D; Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece. Electronic address: patoulias@auth.gr.
  • Popovic DS; Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Medical Faculty, University of Novi Sad, Novi Sad, Serbia.
  • Stoian AP; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, Medical Center, University of Ljubljana Medical Faculty, Ljubljana, Slovenia.
  • Sahebkar A; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Applied Biomedical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rizzo M; School of Medicine, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Italy.
J Diabetes Complications ; 37(8): 108529, 2023 08.
Article de En | MEDLINE | ID: mdl-37301063

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Hypoglycémiants Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: J Diabetes Complications Sujet du journal: ENDOCRINOLOGIA Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Hypoglycémiants Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: J Diabetes Complications Sujet du journal: ENDOCRINOLOGIA Année: 2023 Type de document: Article